Geoffrey Baker
Founder at BSF ENTERPRISE PLC
Net worth: 94 331 $ as of 2024-05-30
Profile
Geoffrey Robert Baker is the founder of BSF Enterprise Plc, which was founded in 2018.
He held the title of Secretary & Non-Executive Director at the company.
Currently, Mr. Baker is the Non-Executive Chairman at Key Petroleum Ltd.
since 2014, the Non-Executive Director at Activex Ltd.
since 2013, the Non-Executive Director at Rey Resources Ltd.
since 2012, and the Non-Executive Director at ASF Group Ltd.
since 2006.
He also holds positions as a Director at Suntimes International Ltd., Redstrike Group Ltd., and 3D Bio-Tissues Ltd.
Mr. Baker previously worked as a Non-Executive Director at Metaliko Resources Ltd.
from 2014 to 2017.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BSF ENTERPRISE PLC
1.51% | 2023-09-29 | 1,559,699 ( 1.51% ) | 94 331 $ | 2024-05-30 |
Geoffrey Baker active positions
| Companies | Position | Start |
|---|---|---|
| ASF GROUP LIMITED | Director/Board Member | 2006-11-29 |
| REY RESOURCES LIMITED | Director/Board Member | 2012-09-12 |
| KEY PETROLEUM LIMITED | Chairman | 2020-08-27 |
| ACTIVEX LIMITED | Director/Board Member | 2013-02-14 |
| BSF ENTERPRISE PLC | Founder | 2018-09-04 |
| Suntimes International Ltd. | Director/Board Member | 2011-02-06 |
| Redstrike Group Ltd. | Director/Board Member | - |
3D Bio-Tissues Ltd.
 3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Director/Board Member | - |
Former positions of Geoffrey Baker
| Companies | Position | End |
|---|---|---|
| METALIKO RESOURCES LIMITED | Director/Board Member | 2017-01-11 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ASF GROUP LIMITED | Finance |
| REY RESOURCES LIMITED | Energy Minerals |
| KEY PETROLEUM LIMITED | Energy Minerals |
| ACTIVEX LIMITED | Non-Energy Minerals |
| BSF ENTERPRISE PLC | Finance |
| Private companies | 4 |
|---|---|
| Suntimes International Ltd. | |
Metaliko Resources Ltd.
 Metaliko Resources Ltd. Precious MetalsNon-Energy Minerals Metaliko Resources Ltd. engages in the exploration for gold. Its portfolio consists of the Goongarrie, Bullabulling, Windanya, Anthill, Baden Powell, Jenny Wren and Sevan Seas projects. The company was founded on July 1. 2007 and is headquartered in Nedlands, Australia. | Non-Energy Minerals |
| Redstrike Group Ltd. | |
3D Bio-Tissues Ltd.
3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Health Technology |
- Stock Market
- Insiders
- Geoffrey Baker
